1-16160298-A-G
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000426353.1(EPHA2-AS1):n.161+872A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.867 in 152,222 control chromosomes in the GnomAD database, including 58,337 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
ENST00000426353.1 intron
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000426353.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EPHA2-AS1 | NR_187272.1 | n.751-1203A>G | intron | N/A | |||||
| EPHA2-AS1 | NR_187273.1 | n.750+3119A>G | intron | N/A | |||||
| EPHA2-AS1 | NR_187275.1 | n.750+3119A>G | intron | N/A |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EPHA2-AS1 | ENST00000426353.1 | TSL:3 | n.161+872A>G | intron | N/A | ||||
| EPHA2-AS1 | ENST00000793379.1 | n.526+4543A>G | intron | N/A | |||||
| EPHA2-AS1 | ENST00000793381.1 | n.274+872A>G | intron | N/A |
Frequencies
GnomAD3 genomes AF: 0.867 AC: 131903AN: 152104Hom.: 58322 Cov.: 33 show subpopulations
GnomAD4 genome AF: 0.867 AC: 131963AN: 152222Hom.: 58337 Cov.: 33 AF XY: 0.868 AC XY: 64627AN XY: 74426 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at